BrightGene Bio-Medical Technology Co (688166.SS) Stock Price
BrightGene Bio-Medical Technology Co Price
Over the last 9 years BrightGene Bio-Medical Technology Co grew revenue by 21.6% annually, reaching 1.16 B CNY. Earnings per share have grown at 13.8% per year over the last 9 years. For BrightGene Bio-Medical Technology Co, the net margin of 4.7% is down versus 23.4% a few years ago. At today's price the dividend yield works out to roughly 0.27%. The payout ratio is around 75% of earnings. The dividend has grown at 3.2% per year over the past 5 years. The consensus 12-month price target for BrightGene Bio-Medical Technology Co is 45.09 CNY, about 25.9% above where the stock trades today. Of 5 analysts, 4 rate the stock a buy — an overall Buy consensus.
BrightGene Bio-Medical Technology Co stock price
BrightGene Bio-Medical Technology Co business model & stock analysis
Frequently asked questions about BrightGene Bio-Medical Technology Co
Analysts currently set an average price target of 45.09 CNY for the BrightGene Bio-Medical Technology Co stock (median: 45.09 CNY), implying +25.9 % versus the latest price. The consensus is based on 5 analyst ratings.
BrightGene Bio-Medical Technology Co Analyst Price Targets 2026
5 analysts currently rate the BrightGene Bio-Medical Technology Co stock: 4 recommend buying, 1 holding and 0 selling.
BrightGene Bio-Medical Technology Co Analyst Price Targets 2026
Converted at the current exchange rate, the BrightGene Bio-Medical Technology Co share trades at 4.77 EUR (35.81 CNY).
The expected revenue of BrightGene Bio-Medical Technology Co is 1.64 B CNY. This figure is based on current financial data and reflects the company's business performance.
The profit cannot currently be calculated for BrightGene Bio-Medical Technology Co.
The P/E ratio cannot be calculated for BrightGene Bio-Medical Technology Co at the moment.
The price-to-sales ratio (P/S) of BrightGene Bio-Medical Technology Co is currently 9.23. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the BrightGene Bio-Medical Technology Co stock.
The Eulerpool Quality Score for BrightGene Bio-Medical Technology Co is 2/10.
The ISIN of BrightGene Bio-Medical Technology Co is CNE100003PR1. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The ticker of BrightGene Bio-Medical Technology Co is 688166.SS. The ticker symbol is used to trade BrightGene Bio-Medical Technology Co shares on the stock exchange.
BrightGene Bio-Medical Technology Co stock
BrightGene Bio-Medical Technology Co Peer Group
BrightGene Bio-Medical Technology Co FIGI
All fundamentals and in-depth analysis of BrightGene Bio-Medical Technology Co
Our stock analysis for BrightGene Bio-Medical Technology Co stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of BrightGene Bio-Medical Technology Co. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.